In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Exclusivity Will Not Irreparably Harm Generic Firms, Court Says

Executive Summary

Exclusivity extensions under FDAMA's pediatric provisions will not cause "irreparable harm" to generic drug manufacturers, D.C. Federal Court Judge James Robertson maintained in an April 20 denial of a generics industry motion for preliminary injunction.

You may also be interested in...



GPhA CEO-Designate Jaeger Has Legal, Regulatory Background

Generic Pharmaceutical Association President & CEO Kathleen Jaeger brings experience in legal and regulatory analysis that could help the trade association in its relations with FDA and in legislative drafting

GPhA CEO-Designate Jaeger Has Legal, Regulatory Background

Generic Pharmaceutical Association President & CEO Kathleen Jaeger brings experience in legal and regulatory analysis that could help the trade association in its relations with FDA and in legislative drafting

NAPM Plans To Reiterate Generic Equivalency To MD Groups: AMA, AAP

The National Association of Pharmaceutical Manufacturers is seeking meetings with professional medical societies to reiterate the message that generic drugs are therapeutically equivalent to reference brands.

Related Content

UsernamePublicRestriction

Register

PS034053

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel